1. Home
  2. TUSK vs CRDL Comparison

TUSK vs CRDL Comparison

Compare TUSK & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mammoth Energy Services Inc.

TUSK

Mammoth Energy Services Inc.

HOLD

Current Price

$2.17

Market Cap

102.2M

Sector

Energy

ML Signal

HOLD

Logo Cardiol Therapeutics Inc.

CRDL

Cardiol Therapeutics Inc.

HOLD

Current Price

$0.99

Market Cap

97.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TUSK
CRDL
Founded
2014
2017
Country
United States
Canada
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
102.2M
97.3M
IPO Year
2016
2017

Fundamental Metrics

Financial Performance
Metric
TUSK
CRDL
Price
$2.17
$0.99
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$9.00
AVG Volume (30 Days)
215.1K
323.1K
Earning Date
06-08-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
102.32
N/A
EPS
0.10
N/A
Revenue
$44,292,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$28.22
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.68
$0.77
52 Week High
$2.96
$1.59

Technical Indicators

Market Signals
Indicator
TUSK
CRDL
Relative Strength Index (RSI) 40.50 44.15
Support Level $1.72 $0.95
Resistance Level $2.25 $1.10
Average True Range (ATR) 0.14 0.05
MACD -0.02 -0.01
Stochastic Oscillator 17.72 10.23

Price Performance

Historical Comparison
TUSK
CRDL

About TUSK Mammoth Energy Services Inc.

Mammoth Energy Services Inc is an integrated energy services company engaged in providing products and services to enable the exploration and development of North American onshore unconventional oil and natural gas reserves as well as the construction and repair of the electric grid for private utilities, public investor-owned utilities, and co-operative utilities through infrastructure services businesses. The company had three reportable segments, which includes well completion services (Well Completion), infrastructure services (Infrastructure) and natural sand proppant services (Sand). Key revenue is generated from Infrastructure which include electric utility infrastructure services to government-funded utilities, private utilities, public investor-owned utilities, etc.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

Share on Social Networks: